BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9039065)

  • 1. Sotalol-induced torsades de pointes in patients with renal failure.
    Dancey D; Wulffhart Z; McEwan P
    Can J Cardiol; 1997 Jan; 13(1):55-8. PubMed ID: 9039065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Torsade de pointes with amiodarone in a patient with previous torsade during beta-receptor blockade.
    Skanes AC; Morton BC; Green MS; Tang AS
    Can J Cardiol; 1997 Apr; 13(4):383-6. PubMed ID: 9141970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sotalol and torsades de pointes ventricular tachycardia].
    Petersen HH; Sandøe E
    Ugeskr Laeger; 1996 May; 158(19):2711-6. PubMed ID: 8744073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Torsades de pointes during low-dosage sotalol therapy in haemodialysis patients.
    Huynh-Do U; Wahl C; Sulzer M; Bühler H; Keusch G
    Nephrol Dial Transplant; 1996 Jun; 11(6):1153-4. PubMed ID: 8671988
    [No Abstract]   [Full Text] [Related]  

  • 5. Torsades de pointes with administration of high-dose intravenous d-sotalol to a patient with congestive heart failure.
    Gottlieb SS; Cines M; Marshall J
    Pharmacotherapy; 1997; 17(4):830-1. PubMed ID: 9250567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Torsade de Pointes tachycardia during sotalol treatment of a patient with normal potassium levels].
    Appel JM; Sigurd B
    Ugeskr Laeger; 1996 Jul; 158(28):4093-4. PubMed ID: 8701528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sotalol--atrial fibrillation, reduced renal function and sudden death].
    Bathen J; Madsen S
    Tidsskr Nor Laegeforen; 1998 Oct; 118(26):4086-7. PubMed ID: 9844513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Amiodarone therapy after sotalol-induced torsade de pointes: prolonged QT interval and QT dispersion in differentiation of pro-arrhythmic effects].
    van de Loo A; Klingenheben T; Hohnloser SH
    Z Kardiol; 1994 Dec; 83(12):887-90. PubMed ID: 7846927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and proarrhythmia with the use of d,l-sotalol for sustained ventricular tachyarrhythmias.
    Kühlkamp V; Mermi J; Mewis C; Seipel L
    J Cardiovasc Pharmacol; 1997 Mar; 29(3):373-81. PubMed ID: 9125676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful haemodialysis in sotalol-induced torsade de pointes in a patient with progressive renal failure.
    van Uum SH; van den Merkhof LF; Lucassen AM; Wuis EW; Diemont W
    Nephrol Dial Transplant; 1997 Feb; 12(2):331-3. PubMed ID: 9132656
    [No Abstract]   [Full Text] [Related]  

  • 11. [Sotalol-induced torsade de pointes tachycardia in a 15-month-old infant].
    Sasse M; Paul T; Bergmann P; Kallfelz HC
    Z Kardiol; 1995 Oct; 84(10):863-6. PubMed ID: 7502575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two cases of torsades de pointes caused by sotalol therapy.
    Cammu G; Geelen P; Baetens P; De Vos J; Demeyer I
    Resuscitation; 1999 Jan; 40(1):49-51. PubMed ID: 10321848
    [No Abstract]   [Full Text] [Related]  

  • 13. Torsade de pointes with sotalol overdose treated successfully with lidocaine.
    Assimes TL; Malcolm I
    Can J Cardiol; 1998 May; 14(5):753-6. PubMed ID: 9627533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sotalol-induced Torsade de pointes in a CAPD patient--successful treatment with intermittent peritoneal dialysis.
    Tang S; Lo CY; Lo WK; Tai YT; Chan TM
    Perit Dial Int; 1997; 17(2):207-8. PubMed ID: 9159848
    [No Abstract]   [Full Text] [Related]  

  • 15. Torsades de pointes from terfenadine and sotalol given in combination.
    Feroze H; Suri R; Silverman DI
    Pacing Clin Electrophysiol; 1996 Oct; 19(10):1519-21. PubMed ID: 8904547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. QT prolongation and development of torsades de pointes with the concomitant administration of oral erythromycin base and quinidine.
    Lin JC; Quasny HA
    Pharmacotherapy; 1997; 17(3):626-30. PubMed ID: 9165570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hemiparesis and torsade de pointes under low-dose sotalol therapy].
    Sieber C; Weiss P; Follath F
    Schweiz Med Wochenschr; 1990 Sep; 120(38):1397-9. PubMed ID: 1699270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reproducible induction of "atypical" torsades de pointes by programmed electrical stimulation: a novel form of sotalol-induced proarrhythmia?
    Krishnan SC; Galvin J; McGovern B; Garan H; Ruskin JN
    J Cardiovasc Electrophysiol; 1997 Sep; 8(9):1055-61. PubMed ID: 9300303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sotalol-induced torsades de pointes successfully treated with hemodialysis after failure of conventional therapy.
    Singh SN; Lazin A; Cohen A; Johnson M; Fletcher RD
    Am Heart J; 1991 Feb; 121(2 Pt 1):601-2. PubMed ID: 1990770
    [No Abstract]   [Full Text] [Related]  

  • 20. JTc prolongation with d,l-sotalol in women versus men.
    Lehmann MH; Hardy S; Archibald D; MacNeil DJ
    Am J Cardiol; 1999 Feb; 83(3):354-9. PubMed ID: 10072223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.